Christopher Rozell highlighted the impact of the NIH program, including work with collaborators at Emory and Mt. Sinai that identified a biomarker of disease recovery for patients with treatment-resistant depression.

By: Audra Davidson (audra.davidson@research.gatech.edu)
School of Electrical and Computer Engineering
Blank Space (small)
(text and background only visible when logged in)